Live Breaking News & Updates on பேரரசு தகவல்தொடர்புகள் குழு

Stay updated with breaking news from பேரரசு தகவல்தொடர்புகள் குழு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Pure Extracts Commences Build-Out of Facility in Preparation for Mushroom Extraction and Dealer's Licence


Share:
VANCOUVER, British Columbia, Dec. 16, 2020 (GLOBE NEWSWIRE)
Pure Extracts Technologies Corp. (CSE:PULL) (XFRA: A2QJAJ) ( Pure Extracts or the Company ), a plant-based extraction company, is pleased to announce that it has begun to build-out the 4
th unit in its facility for the extraction of mushrooms and to commence research and development of psilocybin under a Dealer s Licence.
The Company is preparing an application to Health Canada for a Dealer s Licence under the Controlled Drugs and Substances Act (CDSA), which provides, among other things, the framework for legal access to controlled substances, and the control and regulation of production, distribution and sale of psilocybin. ....

United Kingdom , British Columbia , Ben Nikolaevsky , Empire Communications Group , European Union , Submission Of The Company Dealer , Pure Extracts Technologies Corp , Health Canada , Canadian Securities Exchange , Extracts Technologies , Controlled Drugs , Substances Act , Pure Extracts , Standard Processing License , Cannabis Act , ஒன்றுபட்டது கிஂக்டம் , பிரிட்டிஷ் கொலம்பியா , பேரரசு தகவல்தொடர்புகள் குழு , ஐரோப்பிய தொழிற்சங்கம் , சமர்ப்பிப்பு ஆஃப் தி நிறுவனம் வியாபாரி , தூய்மையானது சாறுகள் தொழில்நுட்பங்கள் கார்ப் , ஆரோக்கியம் கனடா , கனடியன் பத்திரங்கள் பரிமாற்றம் , சாறுகள் தொழில்நுட்பங்கள் , கட்டுப்படுத்தப்படுகிறது மருந்துகள் , தூய்மையானது சாறுகள் ,

REPEAT - Pure Extracts Applauds Health Canada SAP for Psilocybin-Assisted Psychotherapy Inclusion


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
REPEAT - Pure Extracts Applauds Health Canada SAP for Psilocybin-Assisted Psychotherapy Inclusion
Pure Extracts Technologies Corp.December 15, 2020 GMT
Special Access Programme Review Considered a Milestone Event Toward Mainstream Acceptance
VANCOUVER, British Columbia, Dec. 15, 2020 (GLOBE NEWSWIRE) Pure Extracts Technologies Corp. (CSE: PULL) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp, and the rapidly emerging functional mushroom sector, is pleased to support Health Canada’s proposed intent to revise the Special Access Programme (SAP) and related regulations to permit certain authorized uses of psilocybin-assisted psychotherapeutic treatments. The intended SAP revision, announced on December 11th, could lead to important new medical applications, particularly in the complex and growing ment ....

United States , United Kingdom , British Columbia , Ben Nikolaevsky , Alexander Macgregor , Access Programme , Health Canada Drug Establishment , Empire Communications Group , Toronto Institute Of Pharmaceutical Technology , Transpharm Canada Inc , Pure Extracts Technologies Corp , European Union , Health Canada , Canadian Securities Exchange , Special Access Programme Review Considered , Milestone Event Toward Mainstream Acceptance , Extracts Technologies , Special Access Programme , Pure Extracts , Dealers Licence , Controlled Drugs , Substances Act , Toronto Institute , Pharmaceutical Technology , North America , Health Canada Drug Establishment License ,

Pure Extracts Applauds Health Canada SAP for Psilocybin-Assisted Psychotherapy Inclusion


VANCOUVER, British Columbia, Dec. 14, 2020 (GLOBE NEWSWIRE)
Pure Extracts Technologies Corp. (CSE: PULL) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp, and the rapidly emerging functional mushroom sector, is pleased to support Health Canada’s proposed intent to revise the Special Access Programme (SAP) and related regulations to permit certain authorized uses of psilocybin-assisted psychotherapeutic treatments. The intended SAP revision, announced on December 11th, could lead to important new medical applications, particularly in the complex and growing mental health sector.
Health Canada’s announcement could act as a milestone achievement driving advanced research initiatives forward. This includes several ongoing clinical trials that consistently indicate breakthrough therapy potential of psilocybin-assisted psychotherapy for a number of mental health patients suffering from conditions where ....

United States , United Kingdom , British Columbia , Ben Nikolaevsky , Alexander Macgregor , Access Programme , Health Canada Drug Establishment , Empire Communications Group , Toronto Institute Of Pharmaceutical Technology , Transpharm Canada Inc , Pure Extracts Technologies Corp , European Union , Health Canada , Canadian Securities Exchange , Special Access Programme Review Considered , Milestone Event Toward Mainstream , Extracts Technologies , Special Access Programme , Pure Extracts , Dealers Licence , Controlled Drugs , Substances Act , Toronto Institute , Pharmaceutical Technology , North America , Health Canada Drug Establishment License ,